Nohla Therapeutics announces Drs Steven Gillis and Brian Daniels to Board along with closing $43.5m Series A financing led by ARCH Venture Partners
– USA, WA – Nohla Therapeutics Inc., a biotechnology company pioneering the field of universal donor cellular therapies for treating patients with life threatening hematological disorders and cancers, today announced the initial closing of a $43.5M Series A financing round.…